UBS AM’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-3,357
| Closed | -$48.3K | – | 2695 |
|
2022
Q1 | $48.3K | Hold |
3,357
| – | – | ﹤0.01% | 2765 |
|
2021
Q4 | $175K | Buy |
3,357
+137
| +4% | +$7.15K | ﹤0.01% | 2779 |
|
2021
Q3 | $188K | Buy |
3,220
+32
| +1% | +$1.87K | ﹤0.01% | 2696 |
|
2021
Q2 | $257K | Buy |
3,188
+93
| +3% | +$7.5K | ﹤0.01% | 2674 |
|
2021
Q1 | $258K | Hold |
3,095
| – | – | ﹤0.01% | 2516 |
|
2020
Q4 | $235K | Hold |
3,095
| – | – | ﹤0.01% | 2470 |
|
2020
Q3 | $330K | Buy |
3,095
+1,595
| +106% | +$170K | ﹤0.01% | 2283 |
|
2020
Q2 | $227K | Sell |
1,500
-1,044
| -41% | -$158K | ﹤0.01% | 2352 |
|
2020
Q1 | $212K | Sell |
2,544
-172
| -6% | -$14.3K | ﹤0.01% | 2255 |
|
2019
Q4 | $459K | Sell |
2,716
-6
| -0.2% | -$1.01K | ﹤0.01% | 2270 |
|
2019
Q3 | $505K | Buy |
2,722
+1,152
| +73% | +$214K | ﹤0.01% | 2294 |
|
2019
Q2 | $359K | Hold |
1,570
| – | – | ﹤0.01% | 2345 |
|
2019
Q1 | $330K | Hold |
1,570
| – | – | ﹤0.01% | 2282 |
|
2018
Q4 | $181K | Hold |
1,570
| – | – | ﹤0.01% | 2418 |
|
2018
Q3 | $360K | Hold |
1,570
| – | – | ﹤0.01% | 2222 |
|
2018
Q2 | $350K | Buy |
1,570
+680
| +76% | +$152K | ﹤0.01% | 2242 |
|
2018
Q1 | $203K | Hold |
890
| – | – | ﹤0.01% | 2369 |
|
2017
Q4 | $233K | Buy |
+890
| New | +$233K | ﹤0.01% | 2235 |
|
2017
Q3 | – | Sell |
-890
| Closed | -$243K | – | 2535 |
|
2017
Q2 | $243K | Buy |
+890
| New | +$243K | ﹤0.01% | 2126 |
|
2016
Q4 | – | Sell |
-1,710
| Closed | -$466K | – | 2514 |
|
2016
Q3 | $466K | Hold |
1,710
| – | – | ﹤0.01% | 2018 |
|
2016
Q2 | $246K | Hold |
1,710
| – | – | ﹤0.01% | 2322 |
|
2016
Q1 | $246K | Hold |
1,710
| – | – | ﹤0.01% | 2318 |
|
2015
Q4 | $367K | Hold |
1,710
| – | – | ﹤0.01% | 2229 |
|
2015
Q3 | $277K | Buy |
+1,710
| New | +$277K | ﹤0.01% | 2325 |
|